NYSE:CVS - CVS Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$56.3249 +0.72 (+1.29 %)
(As of 03/18/2019 09:41 AM ET)
Previous Close$55.60
Today's Range$55.56 - $56.36
52-Week Range$51.93 - $82.15
Volume1.54 million shs
Average Volume13.59 million shs
Market Capitalization$73.06 billion
P/E Ratio7.96
Dividend Yield3.58%
Beta0.95
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Specialty, AccordantCare, SilverScript, Wellpartner, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2017, it had 23 retail specialty pharmacy stores, 18 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,803 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y más, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 37 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryDrug Retail
SectorRetail/Wholesale
CUSIP12665010
Phone401-765-1500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$194.58 billion
Cash Flow$16.4693 per share
Book Value$57.46 per share

Profitability

Net Income$-594,000,000.00

Miscellaneous

Employees246,000
Outstanding Shares1,297,082,000
Market Cap$73.06 billion
Next Earnings Date5/1/2019 (Estimated)
OptionableOptionable

CVS Health (NYSE:CVS) Frequently Asked Questions

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health announced a quarterly dividend on Wednesday, March 6th. Investors of record on Tuesday, April 23rd will be given a dividend of $0.50 per share on Friday, May 3rd. This represents a $2.00 dividend on an annualized basis and a yield of 3.60%. The ex-dividend date is Monday, April 22nd. View CVS Health's Dividend History.

How were CVS Health's earnings last quarter?

CVS Health Corp (NYSE:CVS) posted its quarterly earnings results on Wednesday, February, 20th. The pharmacy operator reported $2.14 EPS for the quarter, topping analysts' consensus estimates of $2.07 by $0.07. The pharmacy operator earned $54.42 billion during the quarter, compared to analyst estimates of $53.78 billion. CVS Health had a negative net margin of 0.31% and a positive return on equity of 17.49%. The company's revenue for the quarter was up 12.5% on a year-over-year basis. During the same period last year, the firm posted $1.92 earnings per share. View CVS Health's Earnings History.

When is CVS Health's next earnings date?

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, May 1st 2019. View Earnings Estimates for CVS Health.

What guidance has CVS Health issued on next quarter's earnings?

CVS Health updated its FY19 earnings guidance on Wednesday, February, 20th. The company provided earnings per share (EPS) guidance of $6.68-6.88 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.34. CVS Health also updated its FY 2019 guidance to $6.68-6.88 EPS.

What price target have analysts set for CVS?

18 equities research analysts have issued twelve-month price targets for CVS Health's shares. Their forecasts range from $68.00 to $100.00. On average, they anticipate CVS Health's stock price to reach $84.1765 in the next twelve months. This suggests a possible upside of 51.4% from the stock's current price. View Analyst Price Targets for CVS Health.

What is the consensus analysts' recommendation for CVS Health?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 3 hold ratings and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Has CVS Health been receiving favorable news coverage?

News coverage about CVS stock has been trending somewhat positive this week, according to InfoTrie Sentiment. The research firm scores the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. CVS Health earned a news sentiment score of 1.1 on InfoTrie's scale. They also gave headlines about the pharmacy operator a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the immediate future.

Who are some of CVS Health's key competitors?

What other stocks do shareholders of CVS Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), Johnson & Johnson (JNJ), Bank of America (BAC), General Electric (GE), Cisco Systems (CSCO), Alibaba Group (BABA), NVIDIA (NVDA), Intel (INTC) and Starbucks (SBUX).

Who are CVS Health's key executives?

CVS Health's management team includes the folowing people:
  • Mr. Larry J. Merlo, CEO & Director (Age 63)
  • Mr. Jonathan C. Roberts, Exec. VP & COO (Age 63)
  • Mr. Thomas Michael Moriarty, Exec. VP, Chief Policy & External Affairs Officer and Gen. Counsel (Age 55)
  • Ms. Eva C. Boratto, Exec. VP & CFO (Age 52)
  • Mr. James D. Clark, Sr. VP, Controller & Chief Accounting Officer (Age 54)

Who are CVS Health's major shareholders?

CVS Health's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (9.12%), FMR LLC (3.85%), Oregon Public Employees Retirement Fund (2.46%), Barrow Hanley Mewhinney & Strauss LLC (1.88%), Northern Trust Corp (1.76%) and Geode Capital Management LLC (1.62%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, Helena Foulkes, James David Clark, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

Which major investors are selling CVS Health stock?

CVS stock was sold by a variety of institutional investors in the last quarter, including American International Group Inc., First American Bank, Parnassus Investments CA, CI Investments Inc., Harris Associates L P, Kiltearn Partners LLP, DNB Asset Management AS and State Treasurer State of Michigan. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, James David Clark, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

Which major investors are buying CVS Health stock?

CVS stock was bought by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, BlackRock Inc., Norges Bank, FMR LLC, Geode Capital Management LLC, Epoch Investment Partners Inc., Northern Trust Corp and Dimensional Fund Advisors LP. Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health.

How do I buy shares of CVS Health?

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS stock can currently be purchased for approximately $55.60.

How big of a company is CVS Health?

CVS Health has a market capitalization of $72.12 billion and generates $194.58 billion in revenue each year. The pharmacy operator earns $-594,000,000.00 in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

What is CVS Health's official website?

The official website for CVS Health is http://www.cvshealth.com.

How can I contact CVS Health?

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]


MarketBeat Community Rating for CVS Health (NYSE CVS)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  1,102 (Vote Outperform)
Underperform Votes:  607 (Vote Underperform)
Total Votes:  1,709
MarketBeat's community ratings are surveys of what our community members think about CVS Health and other stocks. Vote "Outperform" if you believe CVS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/18/2019 by MarketBeat.com Staff

Featured Article: Intrinsic Value

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel